| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 2 |
| 1 | ACETAMINOPHEN 500MG | 2 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 3 | CILOSTAZOL | 2 |
| 4 | DIVALPROEX SODIUM | 2 |
| 5 | GLIPIZIDE | 2 |
| 6 | LISINOPRIL | 2 |
| 7 | METFORMIN | 2 |
| 8 | METFORMIN ER 500 MG | 2 |
| 9 | METFORMIN ER 750 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PURIXAN | 1 | 0.0013 |
| 1 | SOLIFENACIN SUCCIATE | 1 | 0.0005 |
| 2 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| 3 | CILOSTAZOL | 2 | 0.0003 |
| 4 | AMIVANTAMAB-VMJW | 1 | 0.0003 |
| 5 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 1 | 0.0002 |
| 6 | CANAKINUMAB | 1 | 0.0001 |
| 7 | PEGASPARGASE | 1 | 0.0001 |
| 8 | REMDESIVIR | 1 | 0.0001 |
| 9 | DICYCLOMINE HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 2 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Sulfonylurea [EPC] | 3 | 0.0000 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 9 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |